Purchase Order 36C26326P0417
Award Date 4/24/26
Potential Completion Date 5/24/26
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55417, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from the Department of Veterans Affairs' Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on February 6, 2026, with a completion date of February 9, 2026, reflects no set-aside designation and represents a typical procurement structure...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of April 6, 2026. The contract was awarded without a set-aside designation on April 3, 2026. This purchase order falls within Edwards Lifesciences LLC's broader framework relationship with the Department of Veterans Affairs, where the company serves as a primary...
- Edwards Lifesciences LLC, a leading cardiovascular medical device manufacturer and self-certified small disadvantaged business, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, Minnesota) for transcatheter aortic valve replacement (TAVR) systems and related cardiac technologies. The award, issued on March 27, 2026, with an ultimate completion date of April 26, 2026, represents a non-set-aside procurement reflecting Edwards...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of April 27, 2026. The award was issued without a set-aside designation on April 24, 2026, and represents a standalone purchase order for specialized cardiovascular medical devices. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis VA) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of January 20, 2026. This contract, awarded on January 16, 2026, carries no set-aside designation and represents Edwards Lifesciences' specialized supply of advanced cardiovascular medical devices to the Department of Veterans Affairs. The award is structured as a...
- Edwards Lifesciences LLC was awarded a $34K firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of March 3, 2026. This award carries no set-aside designation and represents a direct procurement of specialized cardiovascular medical devices essential to the Department of Veterans Affairs' cardiac care mission. The contract reflects Edwards Lifesciences' established...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on March 20, 2026, with an ultimate completion date of March 23, 2026, reflects the VA's critical need for specialized cardiovascular medical devices to support cardiac surgical programs...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation specializing in advanced cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, MN) on March 13, 2026, with an ultimate completion date of March 16, 2026. The contract, which carries no set-aside designation, is for transcatheter aortic valve replacement (TAVR) systems and related cardiac technologies to support the Department of...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23) awarded Edwards Lifesciences LLC a $34,000 firm fixed-price purchase order for transcatheter aortic valve replacement (TAVR) systems on January 16, 2026, with an ultimate completion date of January 20, 2026. The contract, which carries no set-aside designation, supports the VA's mission to provide specialized cardiac care to veterans in the Minneapolis service area. Edwards Lifesciences LLC, a subsidiary of...
- Edwards Lifesciences LLC was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on January 12, 2026, for transcatheter aortic valve replacement (TAVR) medical devices. The contract, which carries no set-aside designation, is scheduled for completion by February 11, 2026, with performance taking place in Minneapolis, Minnesota. As a subsidiary of Edwards Lifesciences Corporation, a global leader in structural heart disease treatment, the...